Literature DB >> 31825174

Multimodality imaging and three-dimensional printed model in patients with left ventricular outflow tract obstruction.

Yasuhiro Hamatani1,2, Isao Shiraishi3, Tatsuya Nishii4, Atsushi Okada1, Makoto Amaki1, Kizuku Yamasahita5, Yorihiko Matsumoto5, Hideaki Kanzaki1, Tetsuya Fukuda4, Tomoyuki Fujita5, Satoshi Yasuda1, Junjiro Kobayashi5, Chisato Izumi1.   

Abstract

Surgical treatment is an effective therapy and the gold standard for patients with left ventricular outflow tract obstruction (LVOTO) and drug-refractory symptoms. However, it is difficult to arrange a concrete surgical plan due to the heterogenous and complex cardiac anatomy. Three-dimensional (3D) printing is an emerging technology that is able to reproduce complex cardiac anatomy. Here, we present two patients with LVOTO in whom we created 3D printed models. In these two patients, we compared the 3D printed model and the intraoperative findings and confirmed that the 3D printed model we created could reproduce the complex cardiac anatomy including the interventricular septum, papillary muscles, and abnormally thickened chordae. By using 3D printed models, cardiologists and surgeons can comprehend the complex 3D cardiac structure and spatial positional relationship preoperatively and perform surgical rehearsal. 3D printing could be a valuable tool for the management of patients with LVOTO.
© 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Left ventricular outflow tract obstruction; Multimodality imaging; Surgery; Three-dimensional printing

Mesh:

Year:  2019        PMID: 31825174      PMCID: PMC7083429          DOI: 10.1002/ehf2.12566

Source DB:  PubMed          Journal:  ESC Heart Fail        ISSN: 2055-5822


Introduction

Left ventricular outflow tract obstruction (LVOTO) is associated with debilitating symptoms and a poor prognosis.1 Surgical treatment is an effective therapy and the gold standard for patients with LVOTO and drug‐refractory symptoms.2, 3 However, it is difficult to select and make a concrete surgical plan due to the heterogenous and complex cardiac anatomy. Multimodality imaging such as echocardiography and/or computed tomography (CT) is a promising tool for the evaluation of patients with LVOTO. In addition, three‐dimensional (3D) printing is an emerging technology that is able to reproduce complex cardiac anatomy.4 In the field of pediatric cardiology, 3D printed models are reported to be useful for evaluation and simulation of surgical treatment.5 Here, we present two patients with LVOTO who were evaluated using multimodality imaging and 3D printed models.

Case report

We included two patients with LVOTO in whom surgical treatment was planned at our institution. Signed informed consent to create a 3D printed model and to use their medical records was obtained from each patient. 3D printing of the heart was performed using contrast‐enhanced CT data in the diastolic phase. A stereolithography file of the myocardial model was generated using the software Mimics (Materialize, Leuven, Belgium) and exported to a 3D printer system (RM‐6000 II, CMET; Yokohama, Japan). Baseline characteristics of the two patients are summarized in Table 1.
Table 1

Characteristics of the patients with left ventricular outflow tract obstruction

Case 1Case 2
<Backgrounds>
Age (years)7357
SexFemaleFemale
SymptomDyspnoeaChest pain
NYHA functional classIIIII
MedicationsBisoprolol 5 mg, cibenzoline 150 mgBisoprolol 5 mg, verapamil 120 mg, cibenzoline 150 mg
B‐type natriuretic peptide (pg/mL)121635
<Echocardiography>
Left ventricular ejection fraction (%)6565
Maximum wall thickness (mm)1712
Peak pressure gradient at rest (mmHg)14473
SAM of the mitral valve
Degree of mitral regurgitation1+1+
Abnormality of cardiac structureHypertrophied papillary muscle directly inserted into the mitral valveSub‐aortic stenosis and abnormally thickened chordae

NYHA, New York Heart Association; SAM, systolic anterior motion.

Characteristics of the patients with left ventricular outflow tract obstruction NYHA, New York Heart Association; SAM, systolic anterior motion.

Case 1

A 73‐year‐old woman with hypertrophic obstructive cardiomyopathy was referred to our institution for further management of severe dyspnoea. Transthoracic echocardiography showed a symmetrically hypertrophied left ventricle with maximum thickness of 17 mm (Figure ). Peak pressure gradient at the LVOT was 144 mmHg at rest. We performed transesophageal echocardiography and contrast‐enhanced CT for further evaluation of the LVOTO and revealed that both the anterior and posterior papillary muscles were significantly hypertrophied and the anterior papillary muscle was directly inserted into the mitral valve generating the LVOTO (Figure ). At the heart team conference at our institution, it was decided to perform surgical treatment, and a 3D printed model was created. The 3D printed model could reproduce the hypertrophied papillary muscles and the direct insertion of the anterior papillary muscle into the mitral valve. By creating a 3D printed model, we could understand the 3D structure of complex cardiac anatomy and spatial relationship between the interventricular septum, mitral valve, and the papillary muscles from the surgeon's view (Figure ). The intraoperative findings confirmed the existence of severely hypertrophied papillary muscles as indicated preoperatively by the 3D printed model (Figure ).
Figure 1

(A) Transthoracic echocardiography (parasternal long‐axis view). (B) Transesophageal echocardiography. (C) Contract‐enhanced computed tomography. (D, E) The 3D printed model of the patient. View across the mitral valve (D) and across the aortic valve (E). (F) The intraoperative finding across the aortic valve. AML, anterior mitral leaflet; Ao, aorta; AV, aortic valve; LA, left atrium; LCC, left coronary cusp; LV, left ventricle; MV, mitral valve; NCC, non‐coronary cusp; PM, papillary muscle; PML, posterior mitral leaflet; RCC, right coronary cusp.

(A) Transthoracic echocardiography (parasternal long‐axis view). (B) Transesophageal echocardiography. (C) Contract‐enhanced computed tomography. (D, E) The 3D printed model of the patient. View across the mitral valve (D) and across the aortic valve (E). (F) The intraoperative finding across the aortic valve. AML, anterior mitral leaflet; Ao, aorta; AV, aortic valve; LA, left atrium; LCC, left coronary cusp; LV, left ventricle; MV, mitral valve; NCC, non‐coronary cusp; PM, papillary muscle; PML, posterior mitral leaflet; RCC, right coronary cusp.

Case 2

A 57‐year‐old woman previously diagnosed with drug‐refractory symptomatic hypertrophic obstructive cardiomyopathy was referred to our institution. Transthoracic echocardiography showed concentric left ventricular hypertrophy with a maximum wall thickness of 12 mm and a maximum pressure gradient of 73 mmHg across the LVOT at rest. An abnormal structure like thickened chordae was noted in the lateral side of the left ventricle (Figure ); however, the precise mechanism of LVOTO was not revealed. Transesophageal echocardiography and contrast‐enhanced CT showed that the abnormal funicular structure at the basal septum and abnormally thickened chordae caused LVOTO, suggesting that the patient had sub‐aortic stenosis (Figure ). At the heart team conference, it was decided to perform surgery to alleviate LVOTO due to sub‐aortic stenosis, and a 3D printed model was created. The 3D printed model could reproduce the abnormally thickened chordae and sub‐aortic stenosis. The 3D printed model enabled us to comprehend the 3D relationship between the abnormally thickened chordae and the mitral valve (Figure ) and also enabled us to stereographically recognize the extent of sub‐aortic stenosis from the surgeon's view (Figure ). The intraoperative findings confirmed that the patient had sub‐aortic stenosis (Figure ), and the abnormal funicular structure and abnormally thickened chordae were surgically resected.
Figure 2

(A) Transthoracic echocardiography (apical five chamber view). (B) Transesophageal echocardiography. Sub‐aortic stenosis (blue arrow) was noted. (C) Contract‐enhanced computed tomography. Sub‐aortic stenosis (blue arrow) and the abnormally thickened chordae (yellow arrow) were noted. (D, E) The 3D printed model of the patient. Yellow arrow showed the thickened chordae and blue arrow showed the sub‐aortic stenosis. (F) The intraoperative finding across the aortic valve. Abnormal funicular structure (blue arrow) was confirmed. Ao, aorta; AV, aortic valve; LA, left atrium; LV, left ventricle; MV, mitral valve; RA, right atrium; RV, right ventricle.

(A) Transthoracic echocardiography (apical five chamber view). (B) Transesophageal echocardiography. Sub‐aortic stenosis (blue arrow) was noted. (C) Contract‐enhanced computed tomography. Sub‐aortic stenosis (blue arrow) and the abnormally thickened chordae (yellow arrow) were noted. (D, E) The 3D printed model of the patient. Yellow arrow showed the thickened chordae and blue arrow showed the sub‐aortic stenosis. (F) The intraoperative finding across the aortic valve. Abnormal funicular structure (blue arrow) was confirmed. Ao, aorta; AV, aortic valve; LA, left atrium; LV, left ventricle; MV, mitral valve; RA, right atrium; RV, right ventricle.

Discussion

In this report, we evaluated patients with LVOTO using multimodality imaging and created 3D printed models. We found that these modalities could play a certain role in the management of patients with LVOTO.

Multimodality imaging and three‐dimensional printing in patients with left ventricular outflow tract obstruction

The mechanism of LVOTO is multifactorial and heterogenous.6 Abnormality of the mitral subvalvular apparatus and sub‐aortic stenosis can cause LVOTO; however, these abnormalities are sometimes missed in daily practice. In this report, both patients underwent transesophageal echocardiography and contrast‐enhanced CT for the evaluation of LVOTO. These modalities enabled us to further address the mechanism of LVOTO in both case 1 (with a hypertrophied papillary muscle directly inserted into the mitral valve) and case 2 (with sub‐aortic stenosis and abnormally thickened chordae), suggesting the importance of multimodality imaging for the assessment of patients with LVOTO. On the other hand, it is difficult for cardiologists to fully understand the 3D structure of the complex cardiac anatomy. The 3D printed model we created was constructed on a 1:1 scale with reasonable reproducibility and could be turned over from all views. By using the 3D printed model, we could understand the spatial positional relationship between interventricular septum and mitral subvalvular apparatus such as hypertrophied papillary muscles and thickened chordae as shown in Figures 1 and 2. These complex 3D structures were otherwise difficult to understand. By understanding the 3D cardiac structure using a 3D printed model, cardiologists can feedback and improve the performance of imaging modalities such as echocardiography and CT, perhaps resulting in more effective evaluation of patients with LVOTO.

Surgical strategy in patients with left ventricular outflow tract obstruction using three‐dimensional printed model

As well as in other cardiovascular fields, 3D printing could be promising for surgical simulation in patients with LVOTO.7, 8 In this report, we confirmed that 3D printed model could reproduce the interventricular septum, papillary muscles, and abnormally thickened chordae. By using 3D printed models, surgeons can comprehend the complex 3D cardiac structure preoperatively from the surgeon's view and perform surgical rehearsal. Although surgeon did not perform surgical simulation in these two patients because we would like to compare the intact 3D printed model and intraoperative findings, the use of a 3D printed model for operative rehearsal may have a yield, especially in unusual cases in which surgeons confront extremely abnormal anatomy and for young surgeons with less experience. Meanwhile, particularly thin or small structures are not yet printable. Indeed, our 3D printed model could not reproduce some chordae and muscular bundle. Thus, further improvements of the reproducibility are strongly warranted.

Conclusions

In this case series, we evaluated patients with LVOTO using multimodality imaging and 3D printed models. 3D printing could be a valuable tool for the management of patients with LVOTO.

Conflict of interest

None declared.
  9 in total

1.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

Review 2.  Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.

Authors:  Enrico Ammirati; Rachele Contri; Raffaele Coppini; Franco Cecchi; Maria Frigerio; Iacopo Olivotto
Journal:  Eur J Heart Fail       Date:  2016-04-24       Impact factor: 15.534

3.  Utility of a super-flexible three-dimensional printed heart model in congenital heart surgery.

Authors:  Takaya Hoashi; Hajime Ichikawa; Tomohiro Nakata; Masatoshi Shimada; Hideto Ozawa; Akihiko Higashida; Kenichi Kurosaki; Suzu Kanzaki; Isao Shiraishi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2018-11-01

4.  Scan, plan, print, practice, perform: Development and use of a patient-specific 3-dimensional printed model in adult cardiac surgery.

Authors:  Joshua L Hermsen; Thomas M Burke; Stephen P Seslar; David S Owens; Beth A Ripley; Nahush A Mokadam; Edward D Verrier
Journal:  J Thorac Cardiovasc Surg       Date:  2016-08-20       Impact factor: 5.209

Review 5.  Hypertrophic obstructive cardiomyopathy.

Authors:  Josef Veselka; Nandan S Anavekar; Philippe Charron
Journal:  Lancet       Date:  2016-11-30       Impact factor: 79.321

6.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

7.  Simulative operation on congenital heart disease using rubber-like urethane stereolithographic biomodels based on 3D datasets of multislice computed tomography.

Authors:  Isao Shiraishi; Masaaki Yamagishi; Kenji Hamaoka; Masayuki Fukuzawa; Toshikatsu Yagihara
Journal:  Eur J Cardiothorac Surg       Date:  2009-09-15       Impact factor: 4.191

8.  Contrast-enhanced computed tomography with myocardial three-dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy.

Authors:  Yasuhiro Hamatani; Makoto Amaki; Hideaki Kanzaki; Kizuku Yamashita; Yasuteru Nakashima; Atsushi Shibata; Atsushi Okada; Hiroyuki Takahama; Takuya Hasegawa; Yusuke Shimahara; Yasuo Sugano; Tomoyuki Fujita; Isao Shiraishi; Satoshi Yasuda; Junjiro Kobayashi; Toshihisa Anzai
Journal:  ESC Heart Fail       Date:  2017-07-04

9.  Multimodality imaging and three-dimensional printed model in patients with left ventricular outflow tract obstruction.

Authors:  Yasuhiro Hamatani; Isao Shiraishi; Tatsuya Nishii; Atsushi Okada; Makoto Amaki; Kizuku Yamasahita; Yorihiko Matsumoto; Hideaki Kanzaki; Tetsuya Fukuda; Tomoyuki Fujita; Satoshi Yasuda; Junjiro Kobayashi; Chisato Izumi
Journal:  ESC Heart Fail       Date:  2019-12-11
  9 in total
  3 in total

1.  The Role of Multimodality Imaging and 3D Printing in Ventricular Cone Constriction.

Authors:  Maria Victoria Ordoñez; Israel Valverde
Journal:  JACC Case Rep       Date:  2022-09-21

Review 2.  Aneurysmal and obstructive lesions of the left ventricular outflow: evaluation on multidetector computed tomography angiography.

Authors:  Mumun Sinha; Niraj N Pandey; Arun Sharma; Nitin Parashar; Sanjeev Kumar; Gautam Sharma
Journal:  Pol J Radiol       Date:  2021-04-09

3.  Multimodality imaging and three-dimensional printed model in patients with left ventricular outflow tract obstruction.

Authors:  Yasuhiro Hamatani; Isao Shiraishi; Tatsuya Nishii; Atsushi Okada; Makoto Amaki; Kizuku Yamasahita; Yorihiko Matsumoto; Hideaki Kanzaki; Tetsuya Fukuda; Tomoyuki Fujita; Satoshi Yasuda; Junjiro Kobayashi; Chisato Izumi
Journal:  ESC Heart Fail       Date:  2019-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.